RANBP9 (Ran-binding protein 9), also known as RanBPM, is a scaffolding protein involved in diverse cellular processes, including receptor internalization, signal transduction, and amyloid precursor protein (APP) processing . Antibodies targeting RANBP9 are critical tools for studying its role in neurodegenerative diseases, such as Alzheimer's disease, where it enhances β-secretase (BACE1) cleavage of APP .
A biotin-conjugated RANBP9 antibody would typically involve a primary antibody chemically linked to biotin, enabling detection via streptavidin-enzyme conjugates (e.g., HRP or alkaline phosphatase) in techniques like ELISA, Western blot (WB), or immunohistochemistry (IHC).
Role in APP Processing: Studies demonstrate that RANBP9 overexpression reduces cell surface APP by 52% and accelerates APP internalization, promoting β-secretase cleavage and amyloid-β (Aβ) generation .
Domain Interactions: The SPRY-LisH domains of RANBP9 mediate interactions with APP, LRP, and BACE1, facilitating Aβ production .
Validation Data:
If developed, a biotin-conjugated RANBP9 antibody might enable:
Enhanced Signal Amplification: Streptavidin-biotin systems improve sensitivity in low-abundance protein detection.
Multiplex Assays: Compatibility with avidin-coated plates or beads for high-throughput screening.
Cross-Species Studies: Given RANBP9’s conservation, such an antibody could be tested in human, mouse, and rat models .
RanBPM's diverse roles are extensively documented in the literature. Key findings include: